Assessing the management of bone metastases in patients diagnosed with neuroendocrine neoplasms: Re-audit of clinical practice

#3115

Introduction: There remains no global consensus on the optimal management of bone metastases in patients with neuroendocrine neoplasms (BM-NEN).

Aim(s): To re-audit the clinical management of BM-NEN following the incorporation of institutional guidelines (TC-BM Guid) established in 2018 (PMID: 31639796).

Materials and methods: Retrospective study of all patients with BM-NEN diagnosed from Jan-Dec 2019 following TC-BM Guid. Characteristics of BM-NEN and treatment received were evaluated against TC-BM Guid. Statistical analysis was performed using STATA v14.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: García-Torralba E, Lim K, Barriuso J, McNamara M, Hubner R,

Keywords: bone metastases, neuroendocrine neoplasm, skeletal-related events, bisphosphonates, radiotherapy, guidelines,